Triple-negative breast cancer (TNBC), a subset of breast cancer with the absence of estrogen and progesterone receptors (ERs and PRs) and lack of amplification of the human epidermal growth factor receptor 2 (HER2) gene, accounts for 15–20% of all breast cancer [1, 2]. This evidence concerns the gene PGR and breast cancer.